Excavating regulated cell death signatures to predict prognosis, tumor microenvironment and therapeutic response in HR+/HER2- breast cancer

2024-12-1

Predicting lymphoma prognosis using machine learning-based genes associated with lactylation

2024-11-1

SUGT1 regulates the progression of ovarian cancer through the AKT/PI3K/mTOR signaling pathway

2024-11-1

Effect of tumor-derived extracellular vesicle-shuttled lncRNA MALAT1 on proliferation, invasion and metastasis of triple-negative breast cancer by regulating macrophage M2 polarization via the POSTN/Hippo/YAP axis

2024-11-1

Elevation of circulating neutrophil extracellular traps in endometrial cancer: Poor prognostic value of cell-free double-stranded DNA

2024-11-1

Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic response

2024-11-1

Bulk and single-cell RNA sequencing analyses coupled with multiple machine learning to develop a glycosyltransferase associated signature in colorectal cancer

2024-11-1

WDR77 in Pan-Cancer: Revealing expression patterns, genetic insights, and functional roles across diverse tumor types, with a spotlight on colorectal cancer

2024-11-1

The GGCT and REST positive feedback loop promotes tumor growth in Glioma

2024-11-1

The value of T1- and FST2-Weighted-based radiomics nomogram in differentiating pleomorphic adenoma and Warthin tumor

2024-11-1

Oxazine drug-seed induces paraptosis and apoptosis through reactive oxygen species/JNK pathway in human breast cancer cells

2024-11-1

Niraparib plays synergistic antitumor effects with NRT in a mouse ovarian cancer model with HRP

2024-11-1

Radiosensitizing effects of CDK4/6 inhibitors in hormone receptor-positive and HER2-negative breast cancer mediated downregulation of DNA repair mechanism and NF-κB-signaling pathway

2024-11-1

Identification of a biomarker to predict doxorubicin/cisplatin chemotherapy efficacy in osteosarcoma patients using primary, recurrent and metastatic specimens

2024-11-1

Transcriptional regulation of DLGAP5 by AR suppresses p53 signaling and inhibits CD8+ T cell infiltration in triple-negative breast cancer

2024-11-1

IGFBP1 promotes the proliferation and migration of lung adenocarcinoma cells through the PPARα pathway

2024-11-1

Unlocking mitochondrial dysfunction-associated senescence (MiDAS) with NAD+ – A Boolean model of mitochondrial dynamics and cell cycle control

2024-11-1

Tumor immune microenvironmental characteristics in Human Epidermal Growth Factor-2 (HER2) positive esophageal adenocarcinoma: A comparative analysis and biomarker study

2024-11-1

Photoimmunotherapy for cancer treatment based on organic small molecules: Recent strategies and future directions

2024-11-1

GTF2H5 Identified as a crucial synthetic lethal target to counteract chemoresistance in colorectal cancer

2024-11-1

Transcriptomic profiling identifies a nucleotide metabolism-related signature with prognostic power in gliomas

2024-11-1

Improved survival of patients with stage III small-cell lung cancer with primary resection: A SEER-based analysis

2024-11-1

Low cytoplasmic NUB1 protein exerts hypoxic cell death with poorer prognosis in oestrogen receptor negative breast cancer patients

2024-11-1

Therapeutic potential of tLyp-1-EV-shCTCF in inhibiting liver cancer stem cell self-renewal and immune escape via SALL3 modulation in hepatocellular carcinoma

2024-11-1

The role of deubiquitinase USP2 in driving bladder cancer progression by stabilizing EZH2 to epigenetically silence SOX1 expression

2024-11-1

Disulfidptosis-related gene expression reflects the prognosis of drug-resistant cancer patients and inhibition of MYH9 reverses sorafenib resistance

2024-11-1

Tumor perfusion enhancement by focus ultrasound-induced blood-brain barrier opening to potentiate anti-PD-1 immunotherapy of glioma

2024-11-1

Collagen extracellular matrix promotes gastric cancer immune evasion by activating IL4I1-AHR signaling

2024-11-1

A mini-review-cancer energy reprogramming on drug resistance and immune response

2024-11-1

CircCOCH plays a critical role in Hepatocellular carcinoma through modulating miR-450a and activating PI3K/mTOR pathway

2024-11-1

Drug tolerance and persistence in bacteria, fungi and cancer cells: Role of non-genetic heterogeneity

2024-11-1

SLC2A1 boosts the resistance of non-small cell lung cancer to taxanes by stimulating the formation of EPCAM+ cancer stem-like cells via glycolysis

2024-11-1

Targeted gene panel sequencing of liquid and tissue biopsies reveals actionable genomic alterations in Ghanaian metastatic breast cancer cases

2024-11-1

Unraveling the chemotherapeutic potential of taxifolin ruthenium-p-cymene complex in breast carcinoma: Insights into AhR signaling pathway in vitro and in vivo

2024-11-1

Chitinase 3-like-1 (CHI3L1) in the pathogenesis of epidermal growth factor receptor mutant non-small cell lung cancer

2024-11-1

The immunological landscape and silico analysis of key paraptosis regulator LPAR1 in gastric cancer patients

2024-11-1

Combining Mitomycin C with inhibition of BAD phosphorylation enhances apoptotic cell death in advanced cervical cancer

2024-11-1

Neratinib plus dasatinib is highly synergistic in HER2-positive breast cancer in vitro and in vivo

2024-11-1

PPIC-labeled CAFs: Key players in neoadjuvant chemotherapy resistance for gastric cancer

2024-10-1

Spatial correlation between in vivo imaging and immunohistochemical biomarkers: A methodological study

2024-10-1

Comprehensive analysis of CXCL10 and MIP-3a reveals their potential clinical application in hepatocellular carcinoma

2024-10-1

Combination of radiotherapy and PD-L1 blockade induces abscopal responses in EGFR-mutated lung cancer through activating CD8+ T cells

2024-10-1

Multi-omics profiling to identify early plasma biomarkers in pre-diagnostic pancreatic ductal adenocarcinoma: a nested case-control study

2024-10-1

Hsa_Circ_0008035 drives immune evasion of gastric cancer via promoting EXT1-mediated nuclear translocation of PKM2

2024-10-1

Glutamine withdrawal leads to the preferential activation of lipid metabolism in metastatic colorectal cancer

2024-10-1

Cytochrome P450 F3 promotes colorectal cancer via inhibiting NRF2-mediated ferroptosis

2024-10-1

FUBP1 in human cancer: Characteristics, functions, and potential applications

2024-10-1

Ad-VT causes ovarian cancer A2780 cell death via mitochondrial apoptosis and autophagy pathways

2024-10-1

TP53 signature predicts pathological complete response after neoadjuvant chemotherapy for breast cancer: Observational and confirmational study using prospective study cohorts

2024-10-1

Tislelizumab plus neoadjuvant chemotherapy and concurrent chemoradiotherapy versus neoadjuvant chemotherapy and concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: A retrospective study

2024-10-1